Task: Answer the multiple choice question.
Question: Which drug exhibits a 6.805\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a COc1ccc(C2CC(c3ccccc3)Nc3nc(N)nn32)cc1
b Cc1cccc(N2CCN(CC(=O)Nc3ccccc3[N+](=O)[O-])CC2)c1C
c CCC(C(=O)NCCCN1CCN(C)CC1)n1nc(C)n2c(cc3occc32)c1=O
d CCCCn1c(N)c(N(CCC(C)C)C(=O)C2CCN(C(=O)c3ccccc3C)CC2)c(=O)[nH]c1=O
Answer: c. CCC(C(=O)NCCCN1CCN(C)CC1)n1nc(C)n2c(cc3occc32)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C(=O)NCCCN1CCN(C)CC1)n1nc(C)n2c(cc3occc32)c1=O
CCC(C(=O)NCCCN1CCN(C)CC1)n1nc(C)n2c(cc3occc32)c1=O
2-(12-methyl-9-oxo-5-oxa-1,10,11-triazatricyclo[6.4.0.02,6]dodeca-2(6),3,7,11-tetraen-10-yl)-N-[3-(4-methylpiperazin-1-yl)propyl]butanamide